Jump to main content
Jump to site search

Issue 9, 2016
Previous Article Next Article

Copper transporters and chaperones CTR1, CTR2, ATOX1, and CCS as determinants of cisplatin sensitivity

Author affiliations

Abstract

The development of resistance to cisplatin (cDDP) is commonly accompanied by reduced drug uptake or increased efflux. Previous studies in yeast and murine embryonic fibroblasts have reported that the copper (Cu) transporters and chaperones participate in the uptake, efflux, and intracellular distribution of cDDP. However, there is conflicting data from studies in human cells. We used CRISPR-Cas9 genome editing to individually knock out the human copper transporters CTR1 and CTR2 and the copper chaperones ATOX1 and CCS. Isogenic knockout cell lines were generated in both human HEK-293T and ovarian carcinoma OVCAR8 cells. All knockout cell lines had slowed growth compared to parental cells, small changes in basal Cu levels, and varying sensitivities to Cu depending on the gene targeted. However, all of the knockouts demonstrated only modest 2 to 5-fold changes in cDDP sensitivity that did not differ from the range of sensitivities of 10 wild type clones grown from the same parental cell population. We conclude that, under basal conditions, loss of CTR1, CTR2, ATOX1, or CCS does not produce a change in cisplatin sensitivity that exceeds the variance found within the parental population, suggesting that they are not essential to the mechanism by which cDDP enters these cell lines and is transported to the nucleus.

Graphical abstract: Copper transporters and chaperones CTR1, CTR2, ATOX1, and CCS as determinants of cisplatin sensitivity

Back to tab navigation

Publication details

The article was received on 26 Mar 2016, accepted on 27 Apr 2016 and first published on 09 May 2016


Article type: Paper
DOI: 10.1039/C6MT00076B
Author version
available:
Download author version (PDF)
Metallomics, 2016,8, 951-962

  •   Request permissions

    Copper transporters and chaperones CTR1, CTR2, ATOX1, and CCS as determinants of cisplatin sensitivity

    K. M. Bompiani, C. Tsai, F. P. Achatz, J. K. Liebig and S. B. Howell, Metallomics, 2016, 8, 951
    DOI: 10.1039/C6MT00076B

Search articles by author

Spotlight

Advertisements